Repository logo
 

Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation.


Type

Conference Object

Change log

Authors

Zheng, Yue 
Humphry, Melanie 
Maguire, Janet J 
Bennett, Martin R 
Clarke, Murray CH 

Abstract

Necrosis can induce profound inflammation or be clinically silent. However, the mechanisms underlying such tissue specificity are unknown. Interleukin-1α (IL-1α) is a key danger signal released upon necrosis that exerts effects on both innate and adaptive immunity and is considered to be constitutively active. In contrast, we have shown that necrosis-induced IL-1α activity is tightly controlled in a cell type-specific manner. Most cell types examined expressed a cytosolic IL-1 receptor 2 (IL-1R2) whose binding to pro-IL-1α inhibited its cytokine activity. In cell types exhibiting a silent necrotic phenotype, IL-1R2 remained associated with pro-IL-1α. Cell types possessing inflammatory necrotic phenotypes either lacked IL-1R2 or had activated caspase-1 before necrosis, which degraded and dissociated IL-1R2 from pro-IL-1α. Full IL-1α activity required cleavage by calpain after necrosis, which increased its affinity for IL-1 receptor 1. Thus, we report a cell type-dependent process that fundamentally governs IL-1α activity postnecrosis and the mechanism allowing conditional release of this blockade.

Description

Keywords

Animals, Calpain, Caspase 1, Cell Line, Gene Expression Regulation, Humans, Inflammation, Interleukin-1alpha, Mice, Necrosis, Organ Specificity, Protein Binding, Protein Precursors, Proteolysis, Receptors, Interleukin-1 Type II, Signal Transduction

Journal Title

Immunity

Conference Name

Journal ISSN

1074-7613
1097-4180

Volume Title

38

Publisher

Elsevier BV
Sponsorship
British Heart Foundation (None)
British Heart Foundation (None)
British Heart Foundation (None)
British Heart Foundation (None)
This study was supported by British Heart Foundation Grants FS/09/005/26845 (M.C.H.C.), PG/06/024/20354, and RG 04/001 (M.R.B.), and NIHR Cambridge BRC.